We are excited to announce that our lab at the @ohsuknight.bsky.social has received an Excellence in Early-Career Translational Research (EXCEL-T) Award from the @americancancersoc.bsky.social to better understand systemic immune processes in GBM brain cancer. We thank the ACS for their support!

We proudly welcome Xingjia Zhang, BS as a new graduate student in our lab at the OHSU Knight Cancer Institute. Xingjia brings experience in T cell development and metabolism and will contribute to a better understanding of GBM brain tumor immunology. Please join us in welcoming Xingjia to the team 🎉

We are delighted to announce that our lab has recently been awarded a pilot grant from the Albert & Elaine Borchard Foundation (borchardfoundation.org) to investigate immune responses in patients with GBM brain cancer at Oregon Health & Science University!

We proudly welcome Dr. Ian McLean, PhD as a new postdoctoral fellow in our lab at the Knight Cancer Institute (@ohsuknight.bsky.social). Ian brings expertise in integrative systems biology, machine learning, and single-cell genomics. Please join me in welcoming Ian to the team! 🎉

Phil and Penny Knight announce record-breaking $2 billion gift to OHSU’s Knight Cancer Institute! Newly-formed Knight Cancer Group inaugural president, Dr. Brian Druker, MD, discusses the impact this historic gift will have on cancer research and patient care. cancerletter.com/conversation...